These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 22122400)

  • 21. Oxidant/Antioxidant imbalance and the risk of Alzheimer's disease.
    Moneim AE
    Curr Alzheimer Res; 2015; 12(4):335-49. PubMed ID: 25817254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early molecular changes in Alzheimer disease: can we catch the disease in its presymptomatic phase?
    Wirz KT; Keitel S; Swaab DF; Verhaagen J; Bossers K
    J Alzheimers Dis; 2014; 38(4):719-40. PubMed ID: 24072070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease?
    Leuner K; Hauptmann S; Abdel-Kader R; Scherping I; Keil U; Strosznajder JB; Eckert A; Müller WE
    Antioxid Redox Signal; 2007 Oct; 9(10):1659-75. PubMed ID: 17867931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
    Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
    Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
    Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
    J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alzheimer's pathogenesis and its link to the mitochondrion.
    Simoncini C; Orsucci D; Caldarazzo Ienco E; Siciliano G; Bonuccelli U; Mancuso M
    Oxid Med Cell Longev; 2015; 2015():803942. PubMed ID: 25973139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial dysfunction, endoplasmic reticulum stress, and apoptosis in Alzheimer's disease.
    Takuma K; Yan SS; Stern DM; Yamada K
    J Pharmacol Sci; 2005 Mar; 97(3):312-6. PubMed ID: 15750290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease.
    León R; Garcia AG; Marco-Contelles J
    Med Res Rev; 2013 Jan; 33(1):139-89. PubMed ID: 21793014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.
    Srikanth V; Maczurek A; Phan T; Steele M; Westcott B; Juskiw D; Münch G
    Neurobiol Aging; 2011 May; 32(5):763-77. PubMed ID: 19464758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidative stress and the pathogenesis of Alzheimer's disease.
    Zhao Y; Zhao B
    Oxid Med Cell Longev; 2013; 2013():316523. PubMed ID: 23983897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD.
    Sultana R; Boyd-Kimball D; Poon HF; Cai J; Pierce WM; Klein JB; Merchant M; Markesbery WR; Butterfield DA
    Neurobiol Aging; 2006 Nov; 27(11):1564-76. PubMed ID: 16271804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metals and Neuronal Metal Binding Proteins Implicated in Alzheimer's Disease.
    Cristóvão JS; Santos R; Gomes CM
    Oxid Med Cell Longev; 2016; 2016():9812178. PubMed ID: 26881049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease.
    Reddy PH
    J Neurochem; 2006 Jan; 96(1):1-13. PubMed ID: 16305625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can phages cause Alzheimer's disease?
    Dezfulian M; Shokrgozar MA; Sardari S; Parivar K; Javadi G
    Med Hypotheses; 2008 Nov; 71(5):651-6. PubMed ID: 18701222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity.
    Varadarajan S; Yatin S; Aksenova M; Butterfield DA
    J Struct Biol; 2000 Jun; 130(2-3):184-208. PubMed ID: 10940225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics.
    Sultana R; Perluigi M; Butterfield DA
    Antioxid Redox Signal; 2006; 8(11-12):2021-37. PubMed ID: 17034347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resveratrol and Alzheimer's Disease: Mechanistic Insights.
    Ahmed T; Javed S; Javed S; Tariq A; Šamec D; Tejada S; Nabavi SF; Braidy N; Nabavi SM
    Mol Neurobiol; 2017 May; 54(4):2622-2635. PubMed ID: 26993301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired transcription in Alzheimer's disease: key role in mitochondrial dysfunction and oxidative stress.
    Caldeira GL; Ferreira IL; Rego AC
    J Alzheimers Dis; 2013; 34(1):115-31. PubMed ID: 23364141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin resistance, neuroinflammation, and Alzheimer's disease.
    Najem D; Bamji-Mirza M; Chang N; Liu QY; Zhang W
    Rev Neurosci; 2014; 25(4):509-25. PubMed ID: 24622783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A paradigm shift for evaluating pharmacotherapy for Alzheimer's disease: the 10-patient screening protocol.
    Weinstein JD; Gonzalez ER; Egleton RD; Hunt DA
    Consult Pharm; 2013 Jul; 28(7):443-54. PubMed ID: 23835462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.